Hanson Search will be hosting a webinar to discuss the potential impact of Covid-19, both positive and negative, on the reputation of the pharmaceutical industry.
The sudden and dramatic emergence of COVID-19 has focused attention once again on pharma and the needs to research and deliver effective treatments as well as a much-needed vaccine. Right now, the world has arguably never been so engaged in what it takes to make a medicine.
From a reputation perspective, the pharmaceutical industry has long struggled to communicate its value and build trust, despite the incredible advances over the last decade. But the role of the healthcare industry in meeting the challenges of COVID-19 cannot be overstated. Coronavirus has undoubtedly created a shift in the perception of pharma, with conversations moving away from high drug prices, to the industry’s more commendable work to develop vaccines and therapies through various partnerships and collaboration.
We will be looking closely at the current challenges and priorities pharma will be facing from a communications perspective and how this will impact the industry in terms of its reputation.
On Wednesday 13th May at 9.00am BST, we’re bringing together a panel of experts to discuss how pharma can tell its story.
Kristine Kelly; Director of Communications at Novartis UK Oncology
Alexander Davies; Senior Director at Hanover Communications
Elaine Towell; Head of Communications at ABPI
What have been the priorities for pharma companies in terms of communication strategy and implementation the last few months?
As the pandemic evolves what will be the key challenges and opportunities from a communications perspective?
How can pharma tell a positive story about value without being seen as opportunistic?
What impact will this pandemic have on pharma's reputation in the long term?
Register your interest via the form below and we will send you the VC zoom details. Look forward to discussing the topic with you soon.